HLA-C and triple-A syndrome: There were significantly more MHC class IIhigh DCs that infiltrated into the tumor in mice treated with AAA-CD4+ T cells as early as 4 h after therapy, as compared to control mice (10-fold) and auto-CD4+ T cell-treated mice (3-fold) (Fig. 6c).